Bioavailability of oral trimetrexate in patients with acquired immunodeficiency syndrome.

The combination of the lipophilic antifolate trimetrexate and the rescue agent leucovorin has shown promise in the treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. The pharmacokinetic behavior of trimetrexate administered either by intravenous bolus or...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Rogers, P, Allegra, C J, Murphy, R F, Drake, J C, Masur, H, Poplack, D G, Chabner, B A, Parrillo, J E, Lane, H C, Balis, F M
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1988
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172168/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2966610/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.3.324
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!